At the news
? NEUTRALIMPACT 4/10 6-K filed Aug 10, 2026 at 08:00 ET
Alpha Tau Medical announced its intention to dual-list its ordinary shares on the Tel Aviv Stock Exchange (TASE) while maintaining its Nasdaq listing. The company registered all outstanding shares (92,478,154) plus potential future issuances from warrants, options, RSUs, and employee plans for TASE trading. This listing broadens the shareholder base and provides Israeli investors access in local currency and hours, but does not involve raising new capital or changing the Nasdaq status.
- Alpha Tau intends to dual-list on Tel Aviv Stock Exchange (TASE) alongside existing Nasdaq listing.
- Registered shares include 92,478,154 outstanding ordinary shares; up to 36,733,096 shares underlying existing convertible securities (warrants, options, RSUs); up to 12,889,753 from authorized but unissued options; and up to 4,257,358 from the employee share purchase plan.
- No new capital raising or change in Nasdaq listing status involved.
- Shares will trade on TASE under symbol DRTS (English) and a Hebrew symbol.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access